201 related articles for article (PubMed ID: 32250727)
1. Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on
Markowski MC; Sedhom R; Fu W; Gray JCR; Eisenberger MA; Pomper MG; Pienta KJ; Gorin MA; Rowe SP
J Urol; 2020 Sep; 204(3):496-502. PubMed ID: 32250727
[TBL] [Abstract][Full Text] [Related]
2. Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis.
Crocerossa F; Marchioni M; Novara G; Carbonara U; Ferro M; Russo GI; Porpiglia F; Di Nicola M; Damiano R; Autorino R; Cantiello F
J Urol; 2021 Feb; 205(2):356-369. PubMed ID: 32935652
[TBL] [Abstract][Full Text] [Related]
3. [11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.
Giovacchini G; Picchio M; Garcia-Parra R; Mapelli P; Briganti A; Montorsi F; Gianolli L; Messa C
J Urol; 2013 Jan; 189(1):105-10. PubMed ID: 23164385
[TBL] [Abstract][Full Text] [Related]
4. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with
Pienta KJ; Gorin MA; Rowe SP; Carroll PR; Pouliot F; Probst S; Saperstein L; Preston MA; Alva AS; Patnaik A; Durack JC; Stambler N; Lin T; Jensen J; Wong V; Siegel BA; Morris MJ
J Urol; 2021 Jul; 206(1):52-61. PubMed ID: 33634707
[TBL] [Abstract][Full Text] [Related]
5. Predicting
Lee KH; Mena E; Shih J; Lindenberg L; Wood BJ; Pinto PA; Patel KR; Citrin DE; Choyke PL; Turkbey B
Acad Radiol; 2024 Apr; 31(4):1419-1428. PubMed ID: 37775447
[TBL] [Abstract][Full Text] [Related]
6. Prostate Specific Membrane Antigen Targeted
Gorin MA; Rowe SP; Patel HD; Vidal I; Mana-Ay M; Javadi MS; Solnes LB; Ross AE; Schaeffer EM; Bivalacqua TJ; Partin AW; Pienta KJ; Szabo Z; De Marzo AM; Pomper MG; Allaf ME
J Urol; 2018 Jan; 199(1):126-132. PubMed ID: 28736318
[TBL] [Abstract][Full Text] [Related]
7. Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (
Bach-Gansmo T; Nanni C; Nieh PT; Zanoni L; Bogsrud TV; Sletten H; Korsan KA; Kieboom J; Tade FI; Odewole O; Chau A; Ward P; Goodman MM; Fanti S; Schuster DM; Willoch F
J Urol; 2017 Mar; 197(3 Pt 1):676-683. PubMed ID: 27746282
[TBL] [Abstract][Full Text] [Related]
8. Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer.
Meijer D; Luiting HB; van Leeuwen PJ; Remmers S; Jansen BHE; Bodar YJL; Witteveen T; Schaake EE; van der Poel HG; Wondergem M; Busstra MB; Nieuwenhuijzen JA; Meijnen P; Brabander T; van Moorselaar RJA; Hendrikse NH; Oprea-Lager DE; Roobol MJ; Vis AN
J Urol; 2021 Apr; 205(4):1100-1109. PubMed ID: 33207138
[TBL] [Abstract][Full Text] [Related]
9. Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical Prostatectomy.
Luiting HB; van Leeuwen PJ; Remmers S; Donswijk M; Busstra MB; Bakker IL; Brabander T; Stokkel M; van der Poel HG; Roobol MJ
J Urol; 2020 Sep; 204(3):503-510. PubMed ID: 32149575
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of
Lindenberg L; Mena E; Turkbey B; Shih JH; Reese SE; Harmon SA; Lim I; Lin F; Ton A; McKinney YL; Eclarinal P; Citrin DE; Dahut W; Madan R; Wood BJ; Krishnasamy V; Chang R; Levy E; Pinto P; Eary JF; Choyke PL
Radiology; 2020 Sep; 296(3):564-572. PubMed ID: 32633674
[TBL] [Abstract][Full Text] [Related]
11. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
[TBL] [Abstract][Full Text] [Related]
12.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Performance of
Morris MJ; Rowe SP; Gorin MA; Saperstein L; Pouliot F; Josephson D; Wong JYC; Pantel AR; Cho SY; Gage KL; Piert M; Iagaru A; Pollard JH; Wong V; Jensen J; Lin T; Stambler N; Carroll PR; Siegel BA;
Clin Cancer Res; 2021 Jul; 27(13):3674-3682. PubMed ID: 33622706
[TBL] [Abstract][Full Text] [Related]
15.
Farolfi A; Gafita A; Calais J; Eiber M; Afshar-Oromieh A; Spohn F; Barbato F; Weber M; Ilhan H; Cervati V; Wetter A; Hadaschik B; Briganti A; Walz J; Pianori D; Fanti S; Haberkorn U; Herrmann K; Fendler WP
J Urol; 2019 Dec; 202(6):1174-1181. PubMed ID: 31233369
[TBL] [Abstract][Full Text] [Related]
16. Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer.
van Kalmthout LWM; van Melick HHE; Lavalaye J; Meijer RP; Kooistra A; de Klerk JMH; Braat AJAT; Kaldeway HP; de Bruin PC; de Keizer B; Lam MGEH
J Urol; 2020 Mar; 203(3):537-545. PubMed ID: 31487220
[TBL] [Abstract][Full Text] [Related]
17. Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.
Verburg FA; Pfister D; Heidenreich A; Vogg A; Drude NI; Vöö S; Mottaghy FM; Behrendt FF
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):397-403. PubMed ID: 26563121
[TBL] [Abstract][Full Text] [Related]
18. Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen.
Patel A; Dorey F; Franklin J; deKernion JB
J Urol; 1997 Oct; 158(4):1441-5. PubMed ID: 9302139
[TBL] [Abstract][Full Text] [Related]
19. Can
Chen M; Zhuang J; Fu Y; Guo S; Zang S; Ai S; Qiu X; Wang F; Guo H
J Urol; 2021 Apr; 205(4):1082-1089. PubMed ID: 33207140
[TBL] [Abstract][Full Text] [Related]
20. [11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging.
Giovacchini G; Picchio M; Briganti A; Cozzarini C; Scattoni V; Salonia A; Landoni C; Gianolli L; Di Muzio N; Rigatti P; Montorsi F; Messa C
J Urol; 2010 Sep; 184(3):938-43. PubMed ID: 20643445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
